“Mavacamten and the Reframing of Obstructive Hypertrophic Cardiomyopathy As a Medically Treatable Disease”. Journal of Heart and Cardiovascular Science 3, no. 1 (October 5, 2022): 16–21. Accessed October 30, 2026. https://pragmajournals.org/index.php/JHCS/article/view/168.